This is a routine passive disclosure by a large index/asset manager. No change in investment thesis. Monitor future 13F filings for position size changes and any 13D conversion by other holders.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1- T+0 · Nov 10 $43.91entry
- T+1 · 6d ago +1.39%α +0.07% · $44.52
- T+4 · todayOpen
- T+5 · in 4h Pending
- T+20 · in 22d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
State Street Corporation filed a Schedule 13G disclosing a 4.7% passive stake in Rigel Pharmaceuticals as of September 30, 2026. The filing confirms State Street's position as a top institutional holder, consistent with its prior 13F holdings, and carries no activist intent.
Key Financial Metrics
Key Facts
- State Street Corp disclosed beneficial ownership of 879,862 shares of Rigel Pharmaceuticals common stock.
- The stake represents 4.7% of shares outstanding as of September 30, 2026.
- The filing is a new Schedule 13G (not an amendment) under Rule 13d-1(b), certifying passive intent.
- State Street is a large custodian bank and index fund manager; its 13F as of Q2 2026 showed a $41M position in RIGL.
- The filing was made five days after Rigel reported Q3 2026 earnings (revenue $80.9M, GAAP EPS $0.65).
Financial Impact
4.7% of shares outstanding, valued at approximately $35M based on $747M market cap
Risk Factors
- No activist or control intent is signaled; the filing is purely informational.
- State Street's stake is below the 5% threshold that would trigger a 13G filing; the filing appears to be a voluntary disclosure or a correction.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0000093751-26-000717 |
| Document: 0000093751-26-000717-index.html | 0000093751-26-000717 |
| Document: 0000093751-26-000717.txt | 0000093751-26-000717 |
Track record
12 reports on RIGL
1 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +25.02% at T+60 after the May 12, 2026 report. 2 of 4 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $45.03 Now $43.73 −2.89% settles Feb 12
- Nov 13, 20263d ago SC 13G Neutral 3/10 Entry $44.21 Now $43.73 −1.09% settles Feb 12
- Nov 10, 20266d ago SC 13G Neutral 3/10 Viewing Entry $43.91 Now $43.73 −0.41% settles Feb 8
- Nov 5, 202611d ago 8-K Bearish 5/10 Entry $39.65 Now $43.73 −10.29% settles Feb 4
- Aug 4, 202614w ago 8-K Mixed 6/10 Entry $40.48 to $50.92 Now $43.73 +8.03% ▲ +25.79% +25.60% vs SPY
- Jun 17, 202621w ago 8-K Neutral 4/10 Entry $32.91 to $45.35 Now $43.73 +32.88% ▲ +37.80% +35.91% vs SPY
- Jun 11, 202622w ago Institutional Cluster Neutral 3/10 Entry $32.08 to $48.67 Now $43.73 +36.32% ▲ +51.71% +47.32% vs SPY
- May 20, 202625w ago 8-K Neutral 2/10 Entry $29.19 to $42.45 Now $43.73 +49.81% ▲ +45.43% +41.13% vs SPY
- May 12, 202626w ago 8-K Bullish 7/10 Entry $32.13 to $40.17 Now $43.73 +36.10% ▲ +25.02% +20.59% vs SPY
- May 5, 202627w ago 8-K Bearish 7/10 Entry $26.67 to $36.81 Now $43.73 −63.97% ▼ −38.02% −35.96% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers